Case report: Xanthogranulomatous pyelonephritis successfully treated with antibiotics

IF 0.5 Q4 UROLOGY & NEPHROLOGY
Ming Tow Chan , Karthik Thandapani , Bing Cheng Wu , Thomas Paulraj Thamboo , Yen Seow Benjamin Goh
{"title":"Case report: Xanthogranulomatous pyelonephritis successfully treated with antibiotics","authors":"Ming Tow Chan ,&nbsp;Karthik Thandapani ,&nbsp;Bing Cheng Wu ,&nbsp;Thomas Paulraj Thamboo ,&nbsp;Yen Seow Benjamin Goh","doi":"10.1016/j.eucr.2024.102840","DOIUrl":null,"url":null,"abstract":"<div><p>Xanthogranulomatous inflammation (XGI) is an uncommon benign inflammatory disease process characterized by aggregation of lipid laden foamy macrophages, among other inflammatory cells. XGI affecting the kidney and renal pelvis is otherwise known as xanthogranulomatous pyelonephritis (XGP), which has been reported to be present in approximately 5% of all reported xanthogranulomatous cases. The clinical relevance of this disease is that it often mimics malignancy, and preoperative imaging is unable to differentiate between the two. Our case report demonstrated a renal lesion that mimicked malignancy and ultimately required histopathological examination for the diagnosis of XGP. Current consensus remains that surgery is the mainstay form of treatment. However, this case report showed that use of antibiotics alone can be successful as the patient showed significant improvement and resolution on interval imaging.</p></div>","PeriodicalId":38188,"journal":{"name":"Urology Case Reports","volume":"57 ","pages":"Article 102840"},"PeriodicalIF":0.5000,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214442024001943/pdfft?md5=b6f1e27e73119725dedd2c73c14682b7&pid=1-s2.0-S2214442024001943-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urology Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214442024001943","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Xanthogranulomatous inflammation (XGI) is an uncommon benign inflammatory disease process characterized by aggregation of lipid laden foamy macrophages, among other inflammatory cells. XGI affecting the kidney and renal pelvis is otherwise known as xanthogranulomatous pyelonephritis (XGP), which has been reported to be present in approximately 5% of all reported xanthogranulomatous cases. The clinical relevance of this disease is that it often mimics malignancy, and preoperative imaging is unable to differentiate between the two. Our case report demonstrated a renal lesion that mimicked malignancy and ultimately required histopathological examination for the diagnosis of XGP. Current consensus remains that surgery is the mainstay form of treatment. However, this case report showed that use of antibiotics alone can be successful as the patient showed significant improvement and resolution on interval imaging.

病例报告用抗生素成功治疗黄疽性肾盂肾炎
黄疽性炎症(XGI)是一种不常见的良性炎症过程,其特征是带有脂质的泡沫巨噬细胞和其他炎症细胞聚集在一起。影响肾脏和肾盂的 XGI 又被称为黄原细胞瘤性肾盂肾炎(XGP),据报道,在所有报道的黄原细胞瘤病例中,约有 5%存在这种情况。这种疾病的临床意义在于,它常常与恶性肿瘤相似,而术前成像无法区分两者。我们的病例报告显示,肾脏病变与恶性肿瘤相似,最终需要进行组织病理学检查才能确诊为 XGP。目前的共识仍然是手术是主要的治疗方式。然而,本病例报告显示,仅使用抗生素也能取得成功,因为患者的病情有了明显改善,间隔影像学检查也显示病情得到了缓解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Urology Case Reports
Urology Case Reports Medicine-Urology
CiteScore
0.90
自引率
20.00%
发文量
325
审稿时长
37 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信